Physician profile
Harold Hill
NPI 1215916861
$5,392.70
in general payments reported to CMS, 2019-2025
33 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,071 · 2020: $642 · 2021: $760 · 2022: $916 · 2023: $866 · 2024: $787 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,003.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $856.78 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $798.37 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $601.77 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $595.67 | 2019-2025 | |
| Horizon Therapeutics Plc | $300.23 | 2019-2022 | |
| Allergan, INC. | $204.40 | 2019-2020 | |
| Lilly USA, LLC | $178.45 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Amarin Pharma, INC. | $171.74 | 2019-2021 | |
| Amgen INC. | $144.10 | 2021-2024 | Repatha, Otezla |
| Novo Nordisk INC | $140.58 | 2022-2025 | Ozempic, Rybelsus |
| Dexcom, INC. | $138.64 | 2021-2024 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $133.46 | 2019-2024 | Trintellix |
| Janssen Pharmaceuticals, INC | $124.09 | 2019-2022 | |
| Abbott Laboratories | $115.84 | 2019-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.26 | 2019-2024 | Jardiance, Ofev |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $104.97 | 2019-2022 | |
| Astellas Pharma US INC | $93.85 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $72.34 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.51 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.00 | 2020-2023 | Xifaxan, Trulance |
| Esperion Therapeutics, INC. | $58.20 | 2020-2023 | Nexletol |
| Novartis Pharmaceuticals Corporation | $57.82 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $53.02 | 2023 | Rexulti |
| Nestle Healthcare Nutrition INC. | $40.15 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $38.78 | 2025 | Caplyta |
| Kowa Pharmaceuticals America, INC. | $26.83 | 2022-2025 | Zoryve |
| Axsome Therapeutics, INC. | $23.45 | 2023 | Auvelity |
| Exact Sciences Corporation | $16.04 | 2023 | Cologuard Collection Kit |
| Phadia US INC. | $15.31 | 2019 | |
| Globus Medical, INC. | $15.09 | 2025 | Senza |
| Lundbeck LLC | $14.15 | 2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $11.94 | 2020 | |
| Eisai INC. | $11.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.